Enara Bio
David joined Enara Bio in January 2019 and brings over 30 years of industry experience in functional operations, asset management and executive leadership.
David came to Enara Bio after a successful tenure as VP, Program Leadership at Immunocore where he was able to rapidly build their overall program leadership capability and take responsibility for the lead immuno-oncology program. Previously, David has held a variety of leadership roles within early/late stage clinical development operations in global pharmaceutical companies, including VP, Program Leadership and Management at Biogen. David has been instrumental in successfully building and leading local/regional/global teams, managing external relationships, and driving operational and strategic drug development in both Oncology and Neurology therapeutic areas.
David holds a first-class degree in Biological Sciences (biotechnology) from North East Surrey College of Technology.
This person is not in any offices
Enara Bio
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.